BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 5, Issue 3
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (15385)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.
Item 
Count 
PDF1033
WORD439
HTML8417
Figures (1-2)117
Tables (1-3)125
 Sum=10131
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse599
Download1968
 Sum=2567
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1043
Download1644
 Sum=2687
Sep 26, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Methodology
ISSN
2222-0682
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol 2015; 5(3): 164-174 [PMID: 26413490 DOI: 10.5662/wjm.v5.i3.164]
URL: https://www.wjgnet.com/2222-0682/full/v5/i3/164.htm
Number Citing Articles
1
Dana Binyamin, Nina Pastukh, Avi On, Maya Paritsky, Avi Peretz. Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones. Gut Pathogens 2017; 9(1) doi: 10.1186/s13099-017-0198-5
2
Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors. The Scientific World Journal 2020; 2020: 1 doi: 10.1155/2020/3018326
3
Xiao‐Yan Zhang, Wei‐Xiang Shen, Chun‐Feng Chen, Hai‐Hui Sheng, Hong Cheng, Jiang Li, Fulian Hu, Da‐Ru Lu, Heng‐Jun Gao. Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real‐time PCR. Cancer Medicine 2019; 8(4): 1633 doi: 10.1002/cam4.1986
4
Sepehr Asadi, Ebrahim Rahimi, Amir Shakerian. Helicobacter pylori Strains Isolated from Raw Poultry Meat in the Shahrekord Region, Iran: Frequency and Molecular Characteristics. Genes 2023; 14(5): 1006 doi: 10.3390/genes14051006
5
Ivan Nikolić, Eng Guan Chua, Alfred Chin Yen Tay, Aleksandra Kostrešević, Bojan Pavlović, Katarina Jončić Savić. Savory, Oregano and Thyme Essential Oil Mixture (HerbELICO®) Counteracts Helicobacter pylori. Molecules 2023; 28(5): 2138 doi: 10.3390/molecules28052138
6
Xiaotao Jiang, Chenguang Jiang, Cihui Huang, Guoming Chen, Kailin Jiang, Baoyi Huang, Fengbin Liu. Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/8716910
7
Rita Matos, Emily Taillieu, Sofie De Bruyckere, Chloë De Witte, Alexandra Rêma, Hugo Santos-Sousa, Jorge Nogueiro, Celso A. Reis, Fátima Carneiro, Freddy Haesebrouck, Irina Amorim, Fátima Gärtner. Presence of Helicobacter Species in Gastric Mucosa of Human Patients and Outcome of Helicobacter Eradication Treatment. Journal of Personalized Medicine 2022; 12(2): 181 doi: 10.3390/jpm12020181
8
Burak Sarıkaya, Riza Aytaç Çetinkaya, Derya Özyiğitoğlu, Sinem Akkaya Işık, Mustafa Kaplan, Duygu Kırkık, Levent Görenek. High antibiotic resistance rates in Helicobacter pylori strains in Turkey over 20 years: implications for gastric disease treatment. European Journal of Gastroenterology & Hepatology 2024; 36(5): 545 doi: 10.1097/MEG.0000000000002733
9
Ying Wang, Xianghuan Guo, Shaona Zhou, Leili Wang, Yanyan Fang, Limei Xing, Yuxia Zhao, Li-peng Zhang, Haixia Qiu, Jing Zeng, Ying Gu. Selective photodynamic inactivation of Helicobacter pylori by a cationic benzylidene cyclopentanone photosensitizer - an in vitro and ex vivo study. Journal of Photochemistry and Photobiology B: Biology 2021; 223: 112287 doi: 10.1016/j.jphotobiol.2021.112287
10
Wenyan Xu, Bite Yang, Lang Lin, Qiong Lin, Hui Wang, Lu Yang, Zhongyue Li, Shelby Lamm, Ye Chen, Ningmin Yang, Yishu Chen, Chaohui Yu, Lan Li. Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023. Helicobacter 2024; 29(1) doi: 10.1111/hel.13038
11
You‐hua Wang, Zhi‐fa Lv, Yao Zhong, Dong‐sheng Liu, Shu‐ping Chen, Yong Xie. The internalization of Helicobacter pylori plays a role in the failure of H. pylori eradication. Helicobacter 2017; 22(1) doi: 10.1111/hel.12324
12
Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li. Application of furazolidone in Helicobacter pylori infection eradication. Journal of Digestive Diseases 2024;  doi: 10.1111/1751-2980.13265
13
Sadaf Ejaz, Saima Ejaz, Ramla Shahid, Tayyaba Noor, Saima Shabbir, Muhammad Imran. Chitosan-curcumin complexation to develop functionalized nanosystems with enhanced antimicrobial activity against hetero-resistant gastric pathogen. International Journal of Biological Macromolecules 2022; 204: 540 doi: 10.1016/j.ijbiomac.2022.02.039
14
Ayla Debraekeleer, Han Remaut. Future perspective for potential Helicobacter pylori eradication therapies. Future Microbiology 2018; 13(6): 671 doi: 10.2217/fmb-2017-0115
15
Natalya N. Dekhnich, A.A. Tryapyshko, Ivan V. Trushin, Alexey Yu. Kuzmenkov, Roman S. Kozlov. Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients. Clinical Microbiology and Antimicrobial Chemotherapy 2020; 22(2): 119 doi: 10.36488/cmac.2020.2.119-127
16
Lassaad Chtourou, Manel Moalla, Basma Mnif, Hend Smaoui, Hela Gdoura, Mona Boudabous, Leila Mnif, Ali Amouri, Adnene Hammami, Nabil Tahri. Prevalence of Helicobacter pylori resistance to clarithromycin in Tunisia.  Journal of Medical Microbiology 2022; 71(8) doi: 10.1099/jmm.0.001561
17
Sung Woo Ko, Yeon‐Ji Kim, Woo Chul Chung, Seung Jae Lee. Bismuth supplements as the first‐line regimen for Helicobacter pylori eradication therapy: Systemic review and meta‐analysis. Helicobacter 2019; 24(2) doi: 10.1111/hel.12565
18
Alireza Mohammadzadeh, Mohammad Hassan Minooeianhaghighi, Mohamad Ghorbani, Behdad Zibaee, Jafar Hajavi. Association of ABO and Rh Blood Groups with Helicobacter pylori Seropositivity in Gonabad City, Iran: A Case-Control Study. Zahedan Journal of Research in Medical Sciences 2023; 25(3) doi: 10.5812/zjrms-123100
19
Chiranjeevi Pasala, Chandra Sekhar Reddy Chilamakuri, Sudheer Kumar Katari, Ravina Madhulitha Nalamolu, Aparna R. Bitla, Amineni Umamaheswari. An in silico study: Novel targets for potential drug and vaccine design against drug resistant H. pylori. Microbial Pathogenesis 2018; 122: 156 doi: 10.1016/j.micpath.2018.05.037
20
M. Monsur Ali, Michael Wolfe, Kha Tram, Jimmy Gu, Carlos D. M. Filipe, Yingfu Li, John D. Brennan. A DNAzyme‐Based Colorimetric Paper Sensor for Helicobacter pylori. Angewandte Chemie International Edition 2019; 58(29): 9907 doi: 10.1002/anie.201901873
21
Tural Safarov, Bukre Kiran, Melahat Bagirova, Adil M Allahverdiyev, Emrah Sefik Abamor. An overview of nanotechnology-based treatment approaches against Helicobacter Pylori. Expert Review of Anti-infective Therapy 2019; 17(10): 829 doi: 10.1080/14787210.2019.1677464
22
David Y. Graham, Loren Laine. The Toronto Helicobacter pylori Consensus in Context. Gastroenterology 2016; 151(1): 9 doi: 10.1053/j.gastro.2016.05.009
23
Khaled Mohammad Cheha, Sawsan Omar Ali Dib, Marouf Mohammad Alhalabi. Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience. Avicenna Journal of Medicine 2018; 8(01): 14 doi: 10.4103/ajm.AJM_70_17
24
Rossella Grande, Francesca Sisto, Valentina Puca, Simone Carradori, Maurizio Ronci, Antonio Aceto, Raffaella Muraro, Gabriella Mincione, Luca Scotti. Antimicrobial and Antibiofilm Activities of New Synthesized Silver Ultra-NanoClusters (SUNCs) Against Helicobacter pylori. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.01705
25
Gebremicheal Gebreslassie Kasahun, Gebre Teklemariam Demoz, Desilu Mahari Desta. <p>Primary Resistance Pattern of <em>Helicobacter pylori</em> to Antibiotics in Adult Population: A Systematic Review</p>. Infection and Drug Resistance 2020; : 1567 doi: 10.2147/IDR.S250200
26
Vasiliy Ivanovich Reshetnyak, Tatiana Magomedalievna Reshetnyak. Significance of dormant forms of <i>Helicobacter pylori</i> in ulcerogenesis. World Journal of Gastroenterology 2017; 23(27): 4867-4878 doi: 10.3748/wjg.v23.i27.4867
27
Mahdi Tarhini, Mohammad Fayyad-Kazan, Hussein Fayyad-Kazan, Mahmoud Mokbel, Mohammad Nasreddine, Bassam Badran, Ghada Kchour. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. Microbial Pathogenesis 2018; 117: 23 doi: 10.1016/j.micpath.2018.02.010
28
Francisco Cortez Nunes, Emily Taillieu, Teresa Letra Mateus, Sílvia Teixeira, Freddy Haesebrouck, Irina Amorim. Molecular Detection of Metronidazole and Tetracycline Resistance Genes in Helicobacter pylori-Like Positive Gastric Samples from Pigs. Antibiotics 2023; 12(5): 906 doi: 10.3390/antibiotics12050906
29
Yuzhen Xu, Qian Wang, Yunlin Liu, Ruiting Cui, Kaili Lu, Yuwu Zhao. Association between Helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia. Journal of the Neurological Sciences 2016; 362: 73 doi: 10.1016/j.jns.2016.01.025
30
Mohammad Amin Manavi, Mohammad Hosein Fathian Nasab, Fatemeh Dashti, Setareh Moghimi, Parastoo Saniee, Behjat Pouramiri, Alireza Foroumadi, Morteza Pirali-Hamedani. Green and one-pot synthesis of novel amidoalkyl naphthols using triethanolammonium acetate [(OHCH2CH2)3NH][OAc]) ionic liquid and their anti-H.pylori activity. Research on Chemical Intermediates 2022; 48(10): 4049 doi: 10.1007/s11164-022-04803-9
31
Mark Reihill, Lorenzo Guazzelli, Han Remaut, Stefan Oscarson. Synthesis of Fucose Derivatives with Thiol Motifs towards Suicide Inhibition of Helicobacter pylori. Molecules 2020; 25(18): 4281 doi: 10.3390/molecules25184281
32
Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang. Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis. Microbial Pathogenesis 2020; 142: 104075 doi: 10.1016/j.micpath.2020.104075
33
Sohaib Khan, Mohamed Sharaf, Ishfaq Ahmed, Tehsin Ullah Khan, Samah Shabana, Muhammad Arif, Syed Shabi Ul Hassan Kazmi, Chenguang Liu. Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori. Expert Review of Anti-infective Therapy 2022; 20(3): 407 doi: 10.1080/14787210.2022.1990041
34
Tony A. Shindano, Manix I. Masimango, Antoine S. Kishabongo. Efficacy and tolerability of Helicobacter pylori eradication regimes in South Kivu, Eastern of the Democratic Republic of Congo: A single center observational study. Health Science Reports 2024; 7(3) doi: 10.1002/hsr2.1960
35
Nicole A Vita, Shelby M Anderson, Michael D LaFleur, Richard E Lee. Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics. Current Opinion in Microbiology 2022; 70: 102203 doi: 10.1016/j.mib.2022.102203
36
Andrés Jenuer Matta, Diana Carolina Zambrano, Alvaro Jairo Pazos. Punctual mutations in <i>23S rRNA</i> gene of clarithromycin-resistant <i>Helicobacter pylori</i> in Colombian populations. World Journal of Gastroenterology 2018; 24(14): 1531-1539 doi: 10.3748/wjg.v24.i14.1531
37
Donald Cameron, Quak Seng Hock, Musal Kadim, Neelam Mohan, Eell Ryoo, Bhupinder Sandhu, Yuichiro Yamashiro, Chen Jie, Hans Hoekstra, Alfredo Guarino. Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region. World Journal of Gastroenterology 2017; 23(45): 7952-7964 doi: 10.3748/wjg.v23.i45.7952
38
Sameh S. Ali, Manar K. Abd Elnabi, Mohammad M. Alkherkhisy, Abdulkarim Hasan, Fanghua Li, Maha Khalil, Jianzhong Sun, Nessma El-Zawawy. Exploring the potential of Cinnamomum zeylanicum oil against drug resistant Helicobacter pylori-producing cytotoxic genes. Journal of Applied Biomedicine 2022; 20(1): 22 doi: 10.32725/jab.2022.003
39
Eng-Guan Chua, Aleksandra W Debowski, K Mary Webberley, Fanny Peters, Binit Lamichhane, Mun-Fai Loke, Jamuna Vadivelu, Chin-Yen Tay, Barry J Marshall, Michael J Wise. Analysis of core protein clusters identifies candidate variable sites conferring metronidazole resistance inHelicobacter pylori. Gastroenterology Report 2019; 7(1): 42 doi: 10.1093/gastro/goy048
40
Amin Talebi Bezmin Abadi. Helicobacter pylori and Gastric Cancer. Frontiers in Medicine 2016; 3 doi: 10.3389/fmed.2016.00036
41
Reza Ghotaslou, Hamed Ebrahimzadeh Leylabadlo, Mohammad Taghi Akhi, Javid Sadeghi, Leila Yousefi, Abed Zahedi bialvaei, Mohammad Hossein Somi. The importance of Helicobacter pylori tnpA, tnpB, and cagA genes in various gastrointestinal diseases. Molecular Genetics, Microbiology and Virology 2017; 32(1): 62 doi: 10.3103/S0891416817010049
42
Amrit K. Kamboj, Thomas G. Cotter, Amy S. Oxentenko. Helicobacter pylori. Mayo Clinic Proceedings 2017; 92(4): 599 doi: 10.1016/j.mayocp.2016.11.017
43
Mayuna Srisuphanunt, Polrat Wilairatana, Nateelak Kooltheat, Thitinat Duangchan, Gerd Katzenmeier, Joan B. Rose. Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections. Tropical Medicine and Infectious Disease 2023; 8(3): 163 doi: 10.3390/tropicalmed8030163
44
Saumya Das, Manas Kumar Das, Rajashree Das, Valentina Gehlot, Shweta Mahant, Papiya Mitra Mazumder, Sanjita Das, Neha Falls, Vikas Kumar. Isolation, characterization of Berberine from Berberis aristata DC for eradication of resistant Helicobacter pylori. Biocatalysis and Agricultural Biotechnology 2020; 26: 101622 doi: 10.1016/j.bcab.2020.101622
45
Tomokazu Ohishi, Daniel Ken Inaoka, Kiyoshi Kita, Manabu Kawada. Dihydroorotate Dehydrogenase as a Target for the Development of Novel <i>Helicobacter pylori</i>-Specific Antimicrobials. Chemical and Pharmaceutical Bulletin 2018; 66(3): 239 doi: 10.1248/cpb.c17-00796
46
Hyasinta Jaka, Jee Ah. Rhee, Linda Östlundh, Luke Smart, Robert Peck, Andreas Mueller, Christa Kasang, Stephen E. Mshana. The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3099-4
47
Courtney M. Richman, David A. Leiman. Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(9): 1127 doi: 10.1158/1055-9965.EPI-23-0809
48
Tal Domanovich‐Asor, Hillary A. Craddock, Yair Motro, Boris Khalfin, Avi Peretz, Jacob Moran‐Gilad. Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny. Helicobacter 2021; 26(2) doi: 10.1111/hel.12782
49
HAMED EBRAHIMZADEH LEYLABADLO, MINA YEKANI, REZA GHOTASLOU. Helicobacter pylori hopQ alleles (type I and II) in gastric cancer. Biomedical Reports 2016; 4(5): 601 doi: 10.3892/br.2016.634
50
Verena Kohler, Ankita Vaishampayan, Elisabeth Grohmann. Antibacterial Drug Discovery to Combat MDR. 2019; : 25 doi: 10.1007/978-981-13-9871-1_2
51
Saeed Bayati, Nour Amirmozafari, Masoud Alebouyeh, Nastaran Farzi, Nasser Ebrahimi Daryani, Mohammad Reza Zali. Antibiotic Resistance Among Helicobacter pylori Strains Isolated from Patients with Gastric Pathologies Towards Metronidazole, Clarithromycin, and Ciprofloxacin. Archives of Clinical Infectious Diseases 2019; (In Press) doi: 10.5812/archcid.55015
52
Saeed Bayati, Masoud Alebouyeh, Nour Amirmozafari, Nasser Ebrahimi Daryani, Maliheh Talebi, Mohammad Reza Zali. Histological changes in refractory Helicobacter pylori infection and its relationship with increased levels of resistance to antibiotics and therapeutic regimens: one‐year follow‐up. APMIS 2020; 128(1): 25 doi: 10.1111/apm.13001
53
Rongrong Yang, Junjun Li, Xiaoguang Xu, Keyi Xu, Junling Shi. Preventive and therapeutic effects of Lactobacillus rhamnosus SHA113 and its culture supernatant on alcoholic gastric ulcers. Food & Function 2021; 12(16): 7250 doi: 10.1039/D1FO00181G
54
CA Chew, TF Lye, D Ang, TL Ang. The diagnosis and management of H. pylori infection in Singapore. Singapore Medical Journal 2017; 58(5): 234 doi: 10.11622/smedj.2017037
55
Maria Pina Dore, Hong Lu, David Y Graham. Role of bismuth in improvingHelicobacter pylorieradication with triple therapy. Gut 2016; 65(5): 870 doi: 10.1136/gutjnl-2015-311019
56
Ji Yeong Yang, Pumsoo Kim, Seok-Hoo Jeong, Seong Woong Lee, Yu Sik Myung, Myong Ki Baeg, Jong-Bae Kim. The Effects of Sulglycotide on the Adhesion and the Inflammation of Helicobacter Pylori. International Journal of Environmental Research and Public Health 2020; 17(8): 2918 doi: 10.3390/ijerph17082918
57
Sankaran Sathianarayanan, Aparna Viswanathan Ammanath, Raja Biswas, Anita B, Sunitha Sukumaran, Baskar Venkidasamy. A new approach against Helicobacter pylori using plants and its constituents: A review study. Microbial Pathogenesis 2022; 168: 105594 doi: 10.1016/j.micpath.2022.105594
58
Hye Jin Kwon, Min Ho Lee, Hyun Woo Kim, Ji Yeong Yang, Hyun Jun Woo, Min Park, Cheol Moon, Sa-Hyun Kim, Jong-Bae Kim. Riboflavin Inhibits Growth of Helicobacter pylori by Down-regulation of polA and dnaB Genes. Biomedical Science Letters 2020; 26(4): 288 doi: 10.15616/BSL.2020.26.4.288
59
Shu Zhang, Jian Huang, Xiaoqin Xie, Yun He, Fei Mo, Zhaoxun Luo. Quercetin from Polygonum capitatum Protects against Gastric Inflammation and Apoptosis Associated with Helicobacter pylori Infection by Affecting the Levels of p38MAPK, BCL-2 and BAX. Molecules 2017; 22(5): 744 doi: 10.3390/molecules22050744
60
Andrés González, Javier Casado, Eduardo Chueca, Sandra Salillas, Adrián Velázquez-Campoy, Vladimir Espinosa Angarica, Lucie Bénejat, Jérome Guignard, Alban Giese, Javier Sancho, Philippe Lehours, Ángel Lanas. Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection. Pharmaceutics 2019; 11(12): 681 doi: 10.3390/pharmaceutics11120681
61
Ji Yeong Yang, Jong-Bae Kim, Pyeongjae Lee, Sa-Hyun Kim. Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation. International Journal of Molecular Sciences 2021; 22(7): 3385 doi: 10.3390/ijms22073385
62
L. Ladrón-de-Guevara, L. Bornstein-Quevedo, S. González-Huezo, B. Castañeda-Romero, F.G. Costa, M. di Silvio-López. Erradicación de Helicobacter pylori en México con un esquema basado en levofloxacina versus la triple terapia estándar: resultados de un estudio clínico de fase iiib, abierto, aleatorizado, de no inferioridad. Revista de Gastroenterología de México 2019; 84(3): 274 doi: 10.1016/j.rgmx.2018.04.005
63
GHALIA KHODER, ASMA A. AL-MENHALI, FARAH AL-YASSIR, SHERIF M. KARAM. Potential role of probiotics in the management of gastric ulcer. Experimental and Therapeutic Medicine 2016; 12(1): 3 doi: 10.3892/etm.2016.3293
64
Nagendran Tharmalingam, Jenna Port, Dawilmer Castillo, Eleftherios Mylonakis. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22037-x
65
Ian H. Windham, D. Scott Merrell, George O’Toole. Interplay between Amoxicillin Resistance and Osmotic Stress in Helicobacter pylori. Journal of Bacteriology 2022; 204(5) doi: 10.1128/jb.00045-22
66
Ana Bačić, Vladimir Milivojević, Isidora Petković, Dušan Kekić, Ina Gajić, Branislava Medić Brkić, Dušan Popadić, Tomica Milosavljević, Mirjana Rajilić-Stojanović. In Search for Reasons behind Helicobacter pylori Eradication Failure–Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species. Journal of Fungi 2023; 9(3): 328 doi: 10.3390/jof9030328
67
Yunfei Feng, Weibin Zhou, Luo Luo, Weiwei Xu. Helicobacter pylori infection is not related to increased carotid intima-media thickness in general population. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32465-4
68
Razieh Sadat Hosseini, Ghorbanali Rahimian, Mohammad Hadi Shafigh, Majid Validi, Mansoor Khaledi, Abolfazl Gholipour. Correlation between clarithromycin resistance, virulence factors and clinical characteristics of the disease in Helicobacter pylori infected patients in Shahrekord, Southwest Iran. AMB Express 2021; 11(1) doi: 10.1186/s13568-021-01310-9
69
Lyudmila Boyanova, Petyo Hadzhiyski, Nayden Kandilarov, Rumyana Markovska, Ivan Mitov. Multidrug resistance inHelicobacter pylori: current state and future directions. Expert Review of Clinical Pharmacology 2019; 12(9): 909 doi: 10.1080/17512433.2019.1654858
70
Steven F. Moss, William D. Chey, Patrick Daniele, Corey Pelletier, Rinu Jacob, Gabriel Tremblay, Elizabeth Hubscher, Eckhard Leifke, Peter Malfertheiner. Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231167284
71
Behnoush ASGARI, Fatemeh KERMANIAN, Nima DERAKHSHAN, Mohammadreza ASNA-ASHARI, Zahra Rouhani Nojede SADAT, Somayeh YASLIANIFARD. HONEY-DERIVED LACTOBACILLUS RHAMNOSUS ALLEVIATES HELICOBACTER PYLORI-INDUCED GASTRO-INTESTINAL INFECTION AND GASTRIC INFLAMMATION IN C57BL/6 MICE: AN IMMUNO-HISTOLOGIC STUDY. Arquivos de Gastroenterologia 2018; 55(3): 279 doi: 10.1590/s0004-2803.201800000-70
72
Ute Harrison, Muinah A. Fowora, Abiodun T. Seriki, Eva Loell, Susanna Mueller, Margaret Ugo-Ijeh, Charles A. Onyekwere, Olufunmilayo A. Lesi, Jesse A. Otegbayo, Adegboyega Akere, Dennis A. Ndububa, Olusegun Adekanle, Ebere Anomneze, Fatimah B. Abdulkareem, Isaac A. Adeleye, Alexander Crispin, Gabriele Rieder, Wolfgang Fischer, Stella I. Smith, Rainer Haas, Yoshio Yamaoka. Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile. PLOS ONE 2017; 12(5): e0176454 doi: 10.1371/journal.pone.0176454
73
Neus Muñoz, Jordi Sánchez-Delgado, Mireia Baylina, Sheila López-Góngora, Xavier Calvet. Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review. Gastroenterología y Hepatología (English Edition) 2018; 41(10): 654 doi: 10.1016/j.gastre.2018.11.021
74
Petar Knezevic, Verica Aleksic Sabo, Natasa Simin, Marija Lesjak, Neda Mimica-Dukic. A colorimetric broth microdilution method for assessment of Helicobacter pylori sensitivity to antimicrobial agents. Journal of Pharmaceutical and Biomedical Analysis 2018; 152: 271 doi: 10.1016/j.jpba.2018.02.003
75
Raja Singh, Vibha Tandon. Recent Advances in Pharmaceutical Innovation and Research. 2023; : 583 doi: 10.1007/978-981-99-2302-1_24
76
Rajashree Sahoo, A. Swaroop Sanket, Sanghamitra Pati, Rajni Kant, Gaurav Raj Dwivedi. Nanotechnology for Infectious Diseases. 2022; : 321 doi: 10.1007/978-981-16-9190-4_15
77
María R. Baroni, Pamela Bucci, Rita N. Giani, Antonela Giusti, Fabian A. Tedeschi, Emiliano Salvatierra, Yanina Barbaglia, Félix Jimenez, Fabian E. Zalazar. Usefulness of rapid urease test samples for molecular analysis of clarithromycin resistance in Helicobacter pylori. Revista Argentina de Microbiología 2018; 50(4): 359 doi: 10.1016/j.ram.2017.11.005
78
M. G. Rusalenko, M. Wisham, T. V. Konovalova, L. V. Lischenko, I. G. Savasteeva, N. I. Shevchenko. Significance of pathogen identification for urinary tract infection and <i>Helicobacter pylori</i> infection in type 1 and type 2 diabetes mellitus patients. Health and Ecology Issues 2023; 20(2): 35 doi: 10.51523/2708-6011.2023-20-2-05
79
J. Shokri‐Shirvani, V. Zamani, M. Zamani. Letter: global emergence of Helicobacter pylori antibiotic resistance – unanswered questions. Alimentary Pharmacology & Therapeutics 2016; 43(11): 1249 doi: 10.1111/apt.13612
80
Paweł Krzyżek, Roman Franiczek, Barbara Krzyżanowska, Łukasz Łaczmański, Paweł Migdał, Grażyna Gościniak. In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains. Cancers 2019; 11(2): 229 doi: 10.3390/cancers11020229
81
Shuai Hu, Karen M. Ottemann. Helicobacter pylori initiates successful gastric colonization by utilizing L-lactate to promote complement resistance. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-37160-1
82
Anthony Mannion, JoAnn Dzink-Fox, Zeli Shen, M. Blanca Piazuelo, Keith T. Wilson, Pelayo Correa, Richard M. Peek, M. Constanza Camargo, James G. Fox, Erin McElvania. Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations. Journal of Clinical Microbiology 2021; 59(5) doi: 10.1128/JCM.03203-20
83
Abiodun T. Seriki, Stella I. Smith, Adeyemi I. Adeleye, Muinah A. Fowora. Molecular analysis of low-level tetracycline resistance in clinical isolates of Helicobacter pylori among dyspeptic patients in South West Nigeria. Journal of Global Antimicrobial Resistance 2018; 13: 143 doi: 10.1016/j.jgar.2018.01.003
84
Shumaiza Anis, Shakeel R Farooqi, Saad K Niaz. Characterization of Domain V Mutations in Clinical Isolates of Helicobacter pylori in Pakistan and Their Effect on Clarithromycin MIC. Infection and Drug Resistance 2021; : 3393 doi: 10.2147/IDR.S306878
85
Min Lee, Ji Yang, Yoonjung Cho, Hyun Woo, Hye Kwon, Do Kim, Min Park, Cheol Moon, Min Yeon, Hyun Kim, Woo-Duck Seo, Sa-Hyun Kim, Jong-Bae Kim. Inhibitory Effects of Menadione on Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation via NF-κB Inhibition. International Journal of Molecular Sciences 2019; 20(5): 1169 doi: 10.3390/ijms20051169
86
Varocha Mahachai, Ratha‐korn Vilaichone, Rapat Pittayanon, Jarin Rojborwonwitaya, Somchai Leelakusolvong, Monthira Maneerattanaporn, Peranart Chotivitayatarakorn, Sombat Treeprasertsuk, Chomsri Kositchaiwat, Pises Pisespongsa, Pisaln Mairiang, Aziz Rani, Alex Leow, Swe Mon Mya, Yi‐Chia Lee, Sengdao Vannarath, Bouachanh Rasachak, Oung Chakravuth, Moe Myint Aung, Tiing‐Leong Ang, Jose D Sollano, Duc Trong Quach, Inchaya Sansak, Olarn Wiwattanachang, Piyathida Harnsomburana, Ari Fahrial Syam, Yoshio Yamaoka, Kwong‐Ming Fock, Khean‐Lee Goh, Kentaro Sugano, David Graham. Helicobacter pylori management in ASEAN: The Bangkok consensus report. Journal of Gastroenterology and Hepatology 2018; 33(1): 37 doi: 10.1111/jgh.13911
87
Rawaa A. Hussein, Mushtak T.S. Al-Ouqaili, Yasin H. Majeed. Detection of clarithromycin resistance and 23SrRNA point mutations in clinical isolates of Helicobacter pylori isolates: Phenotypic and molecular methods. Saudi Journal of Biological Sciences 2022; 29(1): 513 doi: 10.1016/j.sjbs.2021.09.024
88
Tiing Leong Ang, Kwong Ming Fock, Daphne Ang, Andrew Boon Eu Kwek, Eng Kiong Teo, Subbiah Dhamodaran. The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15‐Year Study. Helicobacter 2016; 21(4): 261 doi: 10.1111/hel.12291
89
Diogo Branquinho, Nuno Miguel Peres de Almeida, Carlos Gregório, Adriano Casela, Maria Manuel Donato, Luís Tomé. Twelve-day quintuple regime containing four antibiotics as a rescue therapy for Helicobacter pylori eradication in the central region of Portugal. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4759/2016
90
I V Maev, D N Andreev. Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy. Terapevticheskii arkhiv 2017; 89(8): 5 doi: 10.17116/terarkh20178985-12
91
N. Zemali, G. Guillemot, J. Jaubert, S. Picot, E. Thomas, J.P. Becquart, G. Camuset, P. Gérardin, A. Michault, S. Kwiatek. Helicobacter pylori resistance to clarithromycin in Reunion Island. Médecine et Maladies Infectieuses 2016; 46(7): 385 doi: 10.1016/j.medmal.2016.06.004
92
Neus Muñoz, Jordi Sánchez-Delgado, Mireia Baylina, Sheila López-Góngora, Xavier Calvet. Prevalencia de las resistencias de Helicobacter pylori tras el fracaso de una primera línea de tratamiento. Revisión sistemática. Gastroenterología y Hepatología 2018; 41(10): 654 doi: 10.1016/j.gastrohep.2018.06.014
93
Jessica H. Zafra-Tanaka, Janeth Tenorio-Mucha, David Villarreal-Zegarra, Rodrigo Carrillo-Larco, Antonio Bernabe-Ortiz, Florian Fischer. Cancer-related mortality in Peru: Trends from 2003 to 2016. PLOS ONE 2020; 15(2): e0228867 doi: 10.1371/journal.pone.0228867
94
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategies. Critical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
95
Yongfu Shao, Yifan Lin, Bojun Wang, Min Miao, Guoliang Ye. Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021. Helicobacter 2022; 27(5) doi: 10.1111/hel.12920
96
Mohammed Safwan Ali Khan, Syeda Umme Kulsoom Khundmiri, Syeda Rukhaiya Khundmiri, Mohammad M. Al-Sanea, Pooi Ling Mok. Fruit-Derived Polysaccharides and Terpenoids: Recent Update on the Gastroprotective Effects and Mechanisms. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00569
97
Jewel Ju Ea Kim, Ildikó Kocsmár, György Miklós Buzás, Ildikó Szirtes, Orsolya Rusz, Csaba Diczházi, Attila Szijártó, István Hritz, Zsuzsa Schaff, András Kiss, Éva Kocsmár, Gábor Lotz. Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1609863
98
Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study. Antibiotics 2021; 10(10): 1242 doi: 10.3390/antibiotics10101242
99
Moon-Young Song, Da-Young Lee, Young-Min Han, Eun-Hee Kim. Anti-Inflammatory Effect of Korean Propolis on Helicobacter pylori-Infected Gastric Mucosal Injury Mice Model. Nutrients 2022; 14(21): 4644 doi: 10.3390/nu14214644
100
Muhan LÜ, Shan Yu, Jiaqi Deng, Qiong Yan, Chun Yang, Guodong Xia, Xian Zhou, Anna Roujeinikova. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials. PLOS ONE 2016; 11(10): e0163743 doi: 10.1371/journal.pone.0163743
101
Farzad Khademi, Amirhossein Sahebkar. An Updated Systematic Review and Meta-Analysis on theHelicobacter pyloriAntibiotic Resistance in Iran (2010–2020). Microbial Drug Resistance 2020; 26(10): 1186 doi: 10.1089/mdr.2020.0088
102
Ahmad Zare Javid, Leila Maghsoumi-Norouzabad, Hadi Bazyar, Vahideh Aghamohammadi, Pejman Alavinejad. <p>Effects of Concurrent Omega-3 and Cranberry Juice Consumption Along with Standard Antibiotic Therapy on the Eradication of <em>Helicobacter pylori</em>, Gastrointestinal Symptoms, Some Serum Inflammatory and Oxidative Stress Markers in Adults with <em>Helicobacter pylori</em> Infection: A Study Protocol for a Randomized Controlled Trial</p>. Infection and Drug Resistance 2020; : 3179 doi: 10.2147/IDR.S270057
103
M. Monsur Ali, Michael Wolfe, Kha Tram, Jimmy Gu, Carlos D. M. Filipe, Yingfu Li, John D. Brennan. A DNAzyme‐Based Colorimetric Paper Sensor for Helicobacter pylori. Angewandte Chemie 2019; 131(29): 10012 doi: 10.1002/ange.201901873
104
Nastaran Farzi, Abbas Yadegar, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Sinéad Marian Smith, Josette Raymond, Hidekazu Suzuki, Mohammad Reza Zali. High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping. Journal of Clinical Medicine 2019; 8(11): 2004 doi: 10.3390/jcm8112004
105
Hyasinta Jaka, Andreas Mueller, Christa Kasang, Stephen E. Mshana. Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4085-1
106
Behtash G. Nezami, Mehul Jani, David Alouani, Daniel D. Rhoads, Navid Sadri, Andrew B. Onderdonk. Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment Failure. Journal of Clinical Microbiology 2019; 57(7) doi: 10.1128/JCM.01834-18
107
L. Ladrón-de-Guevara, L. Bornstein-Quevedo, S. González-Huezo, B. Castañeda-Romero, F.G. Costa, M. di Silvio-López. Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase IIIb trial. Revista de Gastroenterología de México (English Edition) 2019; 84(3): 274 doi: 10.1016/j.rgmxen.2018.09.006
108
Jae Yong Park, Tae-Seop Shin, Ji Hyun Kim, Hong Jip Yoon, Beom Jin Kim, Jae Gyu Kim. The Prevalence of Multidrug Resistance of Helicobacter pylori and Its Impact on Eradication in Korea from 2017 to 2019: A Single-Center Study. Antibiotics 2020; 9(10): 646 doi: 10.3390/antibiotics9100646
109
Ian H. Windham, D. Scott Merrell. Analysis of fitness costs associated with metronidazole and amoxicillin resistance in Helicobacter pylori. Helicobacter 2020; 25(5) doi: 10.1111/hel.12724
110
Kashyapi Chakravarty, Smriti Gaur. Role of Probiotics in Prophylaxis of Helicobacter pylori Infection. Current Pharmaceutical Biotechnology 2019; 20(2): 137 doi: 10.2174/1389201020666190227203107
111
Mohammad-Hossein Haddadi, Babak Negahdari, Roya Asadolahi, Abdollah Bazargani. Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgraduate Medicine 2020; 132(6): 512 doi: 10.1080/00325481.2020.1753406
112
Hyasinta Jaka, Nele Rüttgerodt, Wolfgang Bohne, Andreas Mueller, Uwe Gross, Christa Kasang, Stephen E. Mshana. Helicobacter pyloriMutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8481375
113
Moon-Young Song, Da-Young Lee, Sang-Yong Park, Seul-A Seo, Jeong-Seung Hwang, Soo-Hyeon Heo, Eun-Hee Kim. Steamed Ginger Extract Exerts Anti-inflammatory Effects inHelicobacter pylori-infected Gastric Epithelial Cells through Inhibition of NF-κB. Journal of Cancer Prevention 2021; 26(4): 289 doi: 10.15430/JCP.2021.26.4.289
114
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?. Comparative Immunology, Microbiology and Infectious Diseases 2019; 64: 99 doi: 10.1016/j.cimid.2019.02.010
115
Marouf Alhalabi, Rasha Almokdad. Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial. Trials 2024; 25(1) doi: 10.1186/s13063-024-07906-3
116
Zeinab Asghari Adib, Amir Reza Sharifi, Mohammad Ali Kiani, Hossein Yousefi, Daniel Horák, Uliana Kostiv, Ali Nabavi-Rad, Abbas Yadegar, Mohammad Yaghoubi-Avini, Hamed Golmohammadi. A smart nanopaper sensor for optical diagnosis ofHelicobacter pyloriinfection. Materials Advances 2023; 4(20): 4965 doi: 10.1039/D3MA00612C
117
Tohid Piri-Gharaghie, Ghazal Ghajari, Shakiba Tolou-Shikhzadeh-Yazdi, Mona Aghassizadeh-Sherbaf, Sahar Khorsand-Dehkordi. RETRACTED ARTICLE: Helicobacter pylori strains isolated from raw poultry meat: frequency and molecular characteristics. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38374-5
118
Tal Domanovich-Asor, Yair Motro, Boris Khalfin, Hillary A. Craddock, Avi Peretz, Jacob Moran-Gilad. Genomic Analysis of Antimicrobial Resistance Genotype-to-Phenotype Agreement in Helicobacter pylori. Microorganisms 2020; 9(1): 2 doi: 10.3390/microorganisms9010002
119
Theodore Rokkas, Konstantinos Ekmektzoglou. Advances in the pharmacological and regulatory management of multidrug resistant Helicobacter pylori . Expert Review of Clinical Pharmacology 2023; 16(12): 1229 doi: 10.1080/17512433.2023.2282061
120
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. APMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
121
Masoud Keikha, Majid Eslami, Bahman Yousefi, Abdolmajid Ghasemian, Mohsen Karbalaei. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. Journal of Cellular Physiology 2019; 234(12): 21460 doi: 10.1002/jcp.28870
122
Hyun Jun Woo, Ji Yeong Yang, Pyeongjae Lee, Jong-Bae Kim, Sa-Hyun Kim. Zerumbone Inhibits Helicobacter pylori Urease Activity. Molecules 2021; 26(9): 2663 doi: 10.3390/molecules26092663
123
Vu Van Khien, Duong Minh Thang, Tran Manh Hai, Nguyen Quang Duat, Pham Hong Khanh, Dang Thuy Ha, Tran Thanh Binh, Ho Dang Quy Dung, Tran Thi Huyen Trang, Yoshio Yamaoka. Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam. Gut and Liver 2019; 13(5): 483 doi: 10.5009/gnl18137
124
Natalya N. Dekhnich, A.A. Tryapyshko, Ivan V. Trushin, Alexey Yu. Kuzmenkov, Roman S. Kozlov. Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients. Clinical Microbiology and Antimicrobial Chemotherapy 2020; 22(2): 119 doi: 10.36488/cmac.2020.2.119-127
125
Marouf Alhalabi, Mohammed Waleed Alassi, Kamal Alaa Eddin, Khaled Cheha. Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06356-5
126
Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori. International Journal of Biological Macromolecules 2022; 223: 418 doi: 10.1016/j.ijbiomac.2022.10.265
127
D. S. Bordin, I. N. Voynovan, Yu. V. Embutnieks, O. P. Nyssen, Francis Megraud, Colm O`Morain, J. Perez-Gisbert. European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow. Terapevticheskii arkhiv 2020; 92(2): 12 doi: 10.26442/00403660.2020.02.000567
128
I. Thung, S. E. Crowe, M. A. Valasek. Letter: global emergence of Helicobacter pylori antibiotic resistance – unanswered questions. Authors’ reply. Alimentary Pharmacology & Therapeutics 2016; 43(11): 1249 doi: 10.1111/apt.13625
129
Maria Teresa Mascellino, Alessandra Oliva, Maria Claudia Miele, Massimiliano De Angelis, Giovanni Bruno, Carola Severi. Secondary Antibiotic Resistance, Correlation between Genotypic and Phenotypic Methods and Treatment in Helicobacter pylori Infected Patients: A Retrospective Study. Antibiotics 2020; 9(9): 549 doi: 10.3390/antibiotics9090549
130
Javier P. Gisbert. Rifabutin for the Treatment of Helicobacter pylori Infection: A Review. Pathogens 2020; 10(1): 15 doi: 10.3390/pathogens10010015
131
Manal Diab, Ahmed El-Shenawy, Maged El-Ghannam, Dalia Salem, Moustafa Abdelnasser, Mohamed Shaheen, Mahmoud Abdel-Hady, Effat El-Sherbini, Mohamed Saber. Detection of antimicrobial resistance genes of Helicobacter pylori strains to clarithromycin, metronidazole, amoxicillin and tetracycline among Egyptian patients. Egyptian Journal of Medical Human Genetics 2018; 19(4): 417 doi: 10.1016/j.ejmhg.2018.01.004
132
Seyedeh Amineh Hojati, Sara Kokabpeyk, Salma Yaghoubi, Farahnaz Joukar, Mehrnaz Asgharnezhad, Fariborz Mansour-Ghanaei. Helicobacter pylori infection in Iran: demographic, endoscopic and pathological factors. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01931-1
133
Chiranjeevi Pasala, Sudheer Kumar Katari, Ravina Madhulitha Nalamolu, Aparna R. Bitla, Umamaheswari Amineni. Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of Helicobacter pylori. Cellular and Molecular Bioengineering 2019; 12(3): 255 doi: 10.1007/s12195-019-00572-5
134
Masoud Keikha, Ali Beheshti Namdar. The presence of DupA and clarithromycin resistance in H. pylori among patients with peptic ulcer disease; a rational connection. Gene Reports 2022; 26: 101508 doi: 10.1016/j.genrep.2022.101508
135
Yongming Liu, Chen Shen, Xihui Zhang, Huan Yu, Fujun Wang, Yangyun Wang, Leshuai W Zhang. Exposure and nephrotoxicity concern of bismuth with the occurrence of autophagy. Toxicology and Industrial Health 2018; 34(3): 188 doi: 10.1177/0748233717746810
136
Hamid Abdollahi, Mohammad Hashemzadeh, Saeed Khoshnood, Mohammad Savari. Characterization of Helicobacter pylori genotypes from Iranian patients with gastric clinical diseases: Predominance of vacA s1a and cagA EPIYA-ABC genotypes. Gene Reports 2019; 16: 100458 doi: 10.1016/j.genrep.2019.100458
137
Yanmei Yang, Lijun Bian, Xudong Hang, Caiwang Yan, Yan Huang, Feng Ye, Guoxin Zhang, Guangfu Jin, Hongkai Bi. In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China. Diagnostic Microbiology and Infectious Disease 2020; 98(3): 115129 doi: 10.1016/j.diagmicrobio.2020.115129
138
James Guoxian Huang, Pornthep Tanpowpong. Paediatric gastrointestinal endoscopy in the Asian-Pacific region: Recent advances in diagnostic and therapeutic techniques. World Journal of Gastroenterology 2023; 29(18): 2717-2732 doi: 10.3748/wjg.v29.i18.2717
139
Chenghai Yang, Le Liu, Jerry Kitbok Majaw, Liping Liang, Ye Chen. Efficacy of Lactobacillus reuteri supplementation therapy for Helicobacter pylori eradication: A meta-analysis of randomised controlled trials. Medicine in Microecology 2021; 8: 100036 doi: 10.1016/j.medmic.2021.100036
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345